CXCL12 and cervical carcinoma: In conclusion, this study demonstrates that RTCT increases CXCL12/CXCR4 signalling in cervical cancer, leading to intratumoral accumulation of MDSCs and other myeloid cell populations that may contribute to disease recurrence.